Himuka AM Pharma Corp.
PrivateLast Round
Series B
Jan 14, 2022
Total Funding Raised
$10.67M
Company Overview
Himuka AM Pharma Corp. operates in Healthcare & Life Sciences and is based in Miyazaki. Its latest recorded funding round was a Series B round in January 2022.
Himuka AM Pharma Corp. is a clinical-stage biopharmaceutical company that develops drug candidates based on derivatives of the bioactive peptide adrenomedullin to address unmet medical needs.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Himuka AM Pharma Corp. Comparables
Compare Himuka AM Pharma Corp. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Landos Biopharma | 74% | |
| Sorriso Therapeutics | 70% | |
| MRM Health | 66% |
For institutional investors. Book with your work email.
Himuka AM Pharma Corp. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 14, 2022 | ||||
| Series A | Jun 19, 2018 |
For institutional investors. Book with your work email.
Himuka AM Pharma Corp. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Keio Innovation Initiative | Series A |
| Nanto Bank | Series B |
| 日本ベンチャーキャピタル株式会社 | Series A |
| Miyazaki Taiyo Capital | Series B, Series A |
| Venture Labo Investment | Series B |
| Axil Capital Partners | Series A |
| QB Capital | Series B, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 24, 2026
Monthly visitors grew 40% MoM.
For institutional investors. Book with your work email.
Himuka AM Pharma Corp. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Himuka AM Pharma Corp.'s valuation, stock price, and market status.
Is Himuka AM Pharma Corp. a public or private company?
Himuka AM Pharma Corp. is a private company.
What is the current stock price of Himuka AM Pharma Corp.?
Himuka AM Pharma Corp. is a private company, so its shares have no public market price. Caplight tracks Himuka AM Pharma Corp.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Himuka AM Pharma Corp. worth (valuation)?
Valuation information for Himuka AM Pharma Corp. is not publicly available.
Can I buy Himuka AM Pharma Corp. stock?
Himuka AM Pharma Corp. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Himuka AM Pharma Corp.'s last funding round?
Himuka AM Pharma Corp.'s most recent funding round was Series B on January 14, 2022.
Who are the main investors in Himuka AM Pharma Corp.?
Key investors in Himuka AM Pharma Corp. include Keio Innovation Initiative, Nanto Bank, 日本ベンチャーキャピタル株式会社, Miyazaki Taiyo Capital, Venture Labo Investment.
Will Himuka AM Pharma Corp. IPO soon?
No public IPO plans have been announced for Himuka AM Pharma Corp..
How can I track Himuka AM Pharma Corp. secondary market activity?
Caplight tracks bids, offers, and trades in Himuka AM Pharma Corp.'s shares on secondary markets.